多因素分析之 Logistic回归分析

2018-04-09 MedSci MedSci原创

多因素分析之 Logistic回归分析

多因素分析之 Logistic回归分析




版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1746739, encodeId=48261e46739bf, content=<a href='/topic/show?id=88e91099e10' target=_blank style='color:#2F92EE;'>#logistic回归#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10997, encryptionId=88e91099e10, topicName=logistic回归)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3c135838005, createdName=xlwang2703, createdTime=Sun Dec 09 09:13:00 CST 2018, time=2018-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1671701, encodeId=941916e170160, content=<a href='/topic/show?id=c56c4051902' target=_blank style='color:#2F92EE;'>#回归分析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40519, encryptionId=c56c4051902, topicName=回归分析)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a46f26833520, createdName=cenghis, createdTime=Thu Feb 07 10:13:00 CST 2019, time=2019-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1905769, encodeId=20471905e697b, content=<a href='/topic/show?id=9dc4109964f' target=_blank style='color:#2F92EE;'>#Logistic#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10996, encryptionId=9dc4109964f, topicName=Logistic)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=afa4194, createdName=cenghis, createdTime=Wed Jan 09 17:13:00 CST 2019, time=2019-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1455147, encodeId=2ef2145514e0a, content=<a href='/topic/show?id=bebe8032fc' target=_blank style='color:#2F92EE;'>#GIST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8032, encryptionId=bebe8032fc, topicName=GIST)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e445632366, createdName=july_977, createdTime=Wed Apr 11 06:13:00 CST 2018, time=2018-04-11, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1746739, encodeId=48261e46739bf, content=<a href='/topic/show?id=88e91099e10' target=_blank style='color:#2F92EE;'>#logistic回归#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10997, encryptionId=88e91099e10, topicName=logistic回归)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3c135838005, createdName=xlwang2703, createdTime=Sun Dec 09 09:13:00 CST 2018, time=2018-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1671701, encodeId=941916e170160, content=<a href='/topic/show?id=c56c4051902' target=_blank style='color:#2F92EE;'>#回归分析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40519, encryptionId=c56c4051902, topicName=回归分析)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a46f26833520, createdName=cenghis, createdTime=Thu Feb 07 10:13:00 CST 2019, time=2019-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1905769, encodeId=20471905e697b, content=<a href='/topic/show?id=9dc4109964f' target=_blank style='color:#2F92EE;'>#Logistic#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10996, encryptionId=9dc4109964f, topicName=Logistic)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=afa4194, createdName=cenghis, createdTime=Wed Jan 09 17:13:00 CST 2019, time=2019-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1455147, encodeId=2ef2145514e0a, content=<a href='/topic/show?id=bebe8032fc' target=_blank style='color:#2F92EE;'>#GIST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8032, encryptionId=bebe8032fc, topicName=GIST)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e445632366, createdName=july_977, createdTime=Wed Apr 11 06:13:00 CST 2018, time=2018-04-11, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1746739, encodeId=48261e46739bf, content=<a href='/topic/show?id=88e91099e10' target=_blank style='color:#2F92EE;'>#logistic回归#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10997, encryptionId=88e91099e10, topicName=logistic回归)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3c135838005, createdName=xlwang2703, createdTime=Sun Dec 09 09:13:00 CST 2018, time=2018-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1671701, encodeId=941916e170160, content=<a href='/topic/show?id=c56c4051902' target=_blank style='color:#2F92EE;'>#回归分析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40519, encryptionId=c56c4051902, topicName=回归分析)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a46f26833520, createdName=cenghis, createdTime=Thu Feb 07 10:13:00 CST 2019, time=2019-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1905769, encodeId=20471905e697b, content=<a href='/topic/show?id=9dc4109964f' target=_blank style='color:#2F92EE;'>#Logistic#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10996, encryptionId=9dc4109964f, topicName=Logistic)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=afa4194, createdName=cenghis, createdTime=Wed Jan 09 17:13:00 CST 2019, time=2019-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1455147, encodeId=2ef2145514e0a, content=<a href='/topic/show?id=bebe8032fc' target=_blank style='color:#2F92EE;'>#GIST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8032, encryptionId=bebe8032fc, topicName=GIST)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e445632366, createdName=july_977, createdTime=Wed Apr 11 06:13:00 CST 2018, time=2018-04-11, status=1, ipAttribution=)]
    2019-01-09 cenghis
  4. [GetPortalCommentsPageByObjectIdResponse(id=1746739, encodeId=48261e46739bf, content=<a href='/topic/show?id=88e91099e10' target=_blank style='color:#2F92EE;'>#logistic回归#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10997, encryptionId=88e91099e10, topicName=logistic回归)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3c135838005, createdName=xlwang2703, createdTime=Sun Dec 09 09:13:00 CST 2018, time=2018-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1671701, encodeId=941916e170160, content=<a href='/topic/show?id=c56c4051902' target=_blank style='color:#2F92EE;'>#回归分析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40519, encryptionId=c56c4051902, topicName=回归分析)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a46f26833520, createdName=cenghis, createdTime=Thu Feb 07 10:13:00 CST 2019, time=2019-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1905769, encodeId=20471905e697b, content=<a href='/topic/show?id=9dc4109964f' target=_blank style='color:#2F92EE;'>#Logistic#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10996, encryptionId=9dc4109964f, topicName=Logistic)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=afa4194, createdName=cenghis, createdTime=Wed Jan 09 17:13:00 CST 2019, time=2019-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1455147, encodeId=2ef2145514e0a, content=<a href='/topic/show?id=bebe8032fc' target=_blank style='color:#2F92EE;'>#GIST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8032, encryptionId=bebe8032fc, topicName=GIST)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e445632366, createdName=july_977, createdTime=Wed Apr 11 06:13:00 CST 2018, time=2018-04-11, status=1, ipAttribution=)]
    2018-04-11 july_977

相关资讯

多因素分析之Cox 回归分析

多因素分析之Cox回归分析

大隅良典称将用诺奖奖金设立科研基金

2016年诺贝尔生理学或医学奖得主日本科学家大隅良典日前在瑞典斯德哥尔摩领奖后表示,将拿出部分奖金和东京工业大学合作设立一个科研基金,帮助从事基础研究的年轻研究人员。日本东京工业大学荣誉教授大隅良典单独获得了今年的诺贝尔生理学或医学奖,独享800万瑞典克朗(约合600万元人民币)奖金。他10日在斯德哥尔摩参加了今年的诺贝尔奖颁奖仪式。据日本媒体报道,大隅良典在接受颁奖后表示,将用部分奖金在东京工业

荆清:动脉粥样硬化相关科研基金申请的注意事项

2014年5月30日,由陈桢玥教授,梁春教授主持,荆清教授主讲的“动脉粥样硬化相关科研基金申请的注意事项”在上海国际会议中心举行(OCC 2014大会)。本次讲座主要围绕着国家自然科学基金项目申请准备,撰写项目申请书及注意事项以及申请及评审程序这三个方面进行展开。 首先荆教授简略介绍了下各资助项目的类型资助额度以及资助年限,其中重点介绍了“血管稳态与重构的调控机制”这个项目,荆教授认为该项目资助

2014年CNS--DSM专项科研基金结硕果

2014年CNS—DSM专项科研基金招标工作从2014年3月下旬开始至7月10日结束,共收到来自22个省市地区的项目申请书83份,有效申请62份。 2014年的资助方向为老年营养研究(不含产品开发性研究),收到的62份有效申请项目包含Meta分析18项;与维生素相关研究16项;与PM2.5及空气污染相关研究15项;与植物化合物或Omega-3脂肪酸相关研究13项。 2014年7

春晖渐胜 恰待新锐 ——2017白求恩 朗沐中青年眼科科研基金启动会

四月的黄浦江畔,波光粼粼,草长莺飞。由北京白求恩公益基金会联合中华医学会眼科学分会眼底病学组,在2014年共同发起的“白求恩·朗沐中青年眼科科研基金”迄今已举办两届,青年才俊备至,专家大咖云集,备受好评!4月13日中午12点,第三届“白求恩?朗沐中青年眼科科研基金”启动会于上海在眼底病年会的第一天隆重开幕。为眼科谋,为青年筹!朗沐与我国眼科名家携手,为激励年轻医师砥砺奋进、精进学术倾尽绵薄之力,促